• Ewan Birney, Rolf Apweiler appointed Joint Directors of EMBL-EBI

    Bio-IT World News Brief | Ewan Birney and Rolf Apweiler have been appointed Joint Directors of the European Molecular Biology Laboratory – European Bioinformatics Institute (EMBL-EBI). They will assume their new roles with effect from 1 July 2015. Professor Dame Janet Thornton steps down after 14 years as the EMBL-EBI director.  

    Mar 11, 2015
  • Merck Serono Signs Up with Illumina's Universal Oncology Test

    Bio-IT World News Brief | Illumina has brought another major pharmaceutical partner on board for its Universal Oncology Test program, an effort to build a next-generation sequencing-based gene panel covering all major cancer-related mutations that could be used to select personalized therapies.

    Mar 10, 2015
  • Unstructured Data and the Discovery Problem

    Bio-IT World | Tomorrow the Content Analyst Company will announce the general availability of Cerebrant, a SaaS-based discovery platform designed to enable subject matter experts in any industry to gain rapid insight into unstructured content.

    Mar 9, 2015
  • A Visit to the Digital Brain Library

    Ars Technica | The Digital Brain Library — whose physical collection of donated brains is currently housed at a laboratory in UC San Diego — aims to provide online access to virtual images of at least 1,000 unique human brains photographed at single-micron resolution.

    Mar 9, 2015
  • On the Case at Mount Sinai It’s Dr. Data

    New York Times | Jeffrey Hammerbacher, who started Facebook's data science team, now uses his skills to improve medical treatments, a switch inspired by his own health crisis.

    Mar 9, 2015
  • Zarxio Becomes First FDA-Approved Biosimilar

    Bloomberg | The FDA announced today that Novartis' white blood cell-stimulating drug Zarxio, a biosimilar version of Amgen's Neupogen, has received approval for use in all indications already covered by Neupogen.

    Mar 6, 2015
  • 'Junk DNA' Debates Still Piling Up

    New York Times | Carl Zimmer visits a pair of genetics labs as he digs into the ongoing arguments over whether our genome's vast tracts of noncoding DNA are mostly "junk."

    Mar 5, 2015
  • Bill And Melinda Gates Foundation Makes Its Largest Ever Equity Investment In A Biotech Company

    Forbes | The Bill & Melinda Gates Foundation is investing $52 million in CureVac, a German company involved in making vaccines. It is the largest ever investment by the foundation in a company, reflecting a new strategy of not just giving grants but supporting and having a stake in businesses.

    Mar 5, 2015
  • PacBio at AGBT

    Bio-IT World | Pacific Biosciences, the gold sponsor of this year's Advances in Genome Biology & Technology conference in Florida, hosted a workshop at the event that showed off the growing pipeline of tools for de novo diploid assembly, and ways in which routine use of this information could improve the practice of genomics.

    Mar 3, 2015
  • February News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including guidance from the Association for Molecular Pathology on direct-to-consumer genetic testing, and the winner of the Swimming with the Sharks Competition at the Molecular Medicine Tri Conference.

    Mar 3, 2015